{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T01:20:29Z","timestamp":1787016029989,"version":"build-2736575974"},"reference-count":60,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2019,2,6]],"date-time":"2019-02-06T00:00:00Z","timestamp":1549411200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Transfusion Medicine"],"published-print":{"date-parts":[[2019,8]]},"abstract":"<jats:title>SUMMARY<\/jats:title>\n                  <jats:p>The International Haemovigilance Network (IHN) defines haemovigilance as \u2018a set of surveillance procedures covering the whole transfusion chain (from the collection of blood and its components to the follow\u2010up of recipients), intended to collect and assess information on unexpected or undesirable effects resulting from the therapeutic use of labile blood products, and to prevent their occurrence or recurrence\u2019. IHN, the International Society of Blood Transfusion and World Health Organization work together to support both developing and established haemovigilance systems.<\/jats:p>\n                  <jats:p>Haemovigilance systems provide valuable data on a range of adverse events related to blood donation and clinical transfusion, from donor syncopal events to transfusion\u2010transmitted infections, immunological complications and the impact of human errors. Harmonised definitions for most adverse reactions have been developed and validated internationally. Definitions of pulmonary complications are again under review.<\/jats:p>\n                  <jats:p>Haemovigilance data have resulted in changes in policy, products and practice, and can complement and inform clinical audit and research, leading to improved blood donor safety, optimised product use and better clinical outcomes after transfusion.<\/jats:p>\n                  <jats:p>However, more work is needed. Not all countries have haemovigilance systems in place. More robust data and careful analysis are required to improve the understanding of the causes, occurrence and clinical outcomes of these events. Wider dissemination of results will facilitate health policy development internationally, and implementation of haemovigilance recommendations will support further important progress in blood safety.<\/jats:p>","DOI":"10.1111\/tme.12582","type":"journal-article","created":{"date-parts":[[2019,2,6]],"date-time":"2019-02-06T20:28:18Z","timestamp":1549484898000},"page":"221-230","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":52,"title":["International haemovigilance: what have we learned and what do we need to do next?"],"prefix":"10.1111","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7527-2340","authenticated-orcid":false,"given":"E. M.","family":"Wood","sequence":"first","affiliation":[{"name":"Transfusion Research Unit Monash University  Melbourne Victoria Australia"},{"name":"Department of Clinical Haematology Monash Health  Melbourne Victoria Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. L.","family":"Ang","sequence":"additional","affiliation":[{"name":"Blood Services Group Health Sciences Authority  Singapore"},{"name":"Department of Haematology Singapore General Hospital  Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Bisht","sequence":"additional","affiliation":[{"name":"Haemovigilance Programme of India, National Institute of Biologicals Ministry of Health &amp; Family Welfare  Noida India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6751-7862","authenticated-orcid":false,"given":"P. H.","family":"Bolton\u2010Maggs","sequence":"additional","affiliation":[{"name":"Serious Hazards of Transfusion  Manchester UK"},{"name":"University of Manchester  Manchester UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. G.","family":"Bokhorst","sequence":"additional","affiliation":[{"name":"Transfusion and Transplantation Reactions in Patients (TRIP) National Haemovigilance and Biovigilance Office  Leiden The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Flesland","sequence":"additional","affiliation":[{"name":"Norwegian Directorate of Health  Oslo Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Land","sequence":"additional","affiliation":[{"name":"Blood Systems Inc.  Tempe Arizona USA"},{"name":"Department of Pathology University of Texas Health Science Center  San Antonio Texas USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. C.","family":"Wiersum\u2010Osselton","sequence":"additional","affiliation":[{"name":"Transfusion and Transplantation Reactions in Patients (TRIP) National Haemovigilance and Biovigilance Office  Leiden The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. R.","family":"Schipperus","sequence":"additional","affiliation":[{"name":"Transfusion and Transplantation Reactions in Patients (TRIP) National Haemovigilance and Biovigilance Office  Leiden The Netherlands"},{"name":"Department of Haematology Haga Teaching Hospital  The Hague The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Tiberghien","sequence":"additional","affiliation":[{"name":"Etablissement Fran\u00e7ais du Sang  La Plaine St Denis France"},{"name":"Universit\u00e9 de Franche\u2010Comt\u00e9, Inserm, EFS, UMR 1098  Besan\u00e7on France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. I.","family":"Whitaker","sequence":"additional","affiliation":[{"name":"Office of Biostatistics and Epidemiology Center for Biologics Evaluation and Review US Food &amp; Drug Administration  Silver Spring Maryland USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2019,2,6]]},"reference":[{"key":"e_1_2_11_2_1","unstructured":"Akers C. Wood E. Davis A.K. Bielby L. Glazebrook B. Beard P.&Daly J.(2018) Serious transfusion incident reporting: a key activity of the Australian \u2018Blood Matters\u2019 Blood Management Programme. Abstract O\u2010S3\u20105. Presented at the International Haemovigilance Seminar July 2018 Manchester UK."},{"key":"e_1_2_11_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2007.01457.x"},{"key":"e_1_2_11_4_1","unstructured":"Australian Commission on Safety and Quality in HealthCare(2017)National Safety and Quality Health Service Standards 2nd Edition. URLwww.safetyandquality.gov.au. (Accessed 15\/9\/2018)."},{"key":"e_1_2_11_5_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2016-2955"},{"key":"e_1_2_11_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.12547"},{"key":"e_1_2_11_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.13137"},{"key":"e_1_2_11_8_1","unstructured":"Bolton\u2010Maggs P.&Poles D.on behalf of the SHOT Steering Group(2018)The 2017 Annual SHOT Report. URLwww.shotuk.org(Accessed 14\/9\/2018)."},{"key":"e_1_2_11_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1423-0410.2011.01494.x"},{"key":"e_1_2_11_10_1","unstructured":"Centers for Disease Control and Prevention USA(2018) National Healthcare Safety Network. URLwww.cdc.gov\/nhsn\/acute\u2010care\u2010hospital\/bio\u2010hemo. (Accessed 15\/9\/2018)."},{"key":"e_1_2_11_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/tme.12153"},{"key":"e_1_2_11_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/voxs.12176"},{"key":"e_1_2_11_13_1","unstructured":"Choosing Wisely UK(2016)http:\/\/www.choosingwisely.co.uk\/i\u2010am\u2010a\u2010clinician\/recommendations\/. (Accessed 5\/11\/2018)."},{"key":"e_1_2_11_14_1","doi-asserted-by":"publisher","DOI":"10.1002\/9781118338179.ch2"},{"key":"e_1_2_11_15_1","unstructured":"Department of Health and Human Services Victoria(2018)Blood Matters Programme. URLhttps:\/\/www2.health.vic.gov.au\/hospitals\u2010and\u2010health\u2010services\/patient\u2010care\/speciality\u2010diagnostics\u2010therapeutics\/blood\u2010matters. (Accessed 16\/9\/2018)."},{"key":"e_1_2_11_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tmrv.2009.03.003"},{"key":"e_1_2_11_17_1","unstructured":"European Commission(2002). Directive 2002\/98\/EC\u00a0\u2013\u00a0quality and safety standards for the collection testing processing storage and distribution of human blood and blood components. URLheur\u2010lex.europa.eu\/legal\u2010content\/EN\/TXT\/?uri=celex:32002L0098. (Accessed 14\/9\/2018)."},{"key":"e_1_2_11_18_1","volume-title":"Guide to the Preparation, Use and Quality Assurance of Blood Components","author":"European Directorate for the Quality of Medicines & HealthCare","year":"2017"},{"key":"e_1_2_11_19_1","doi-asserted-by":"publisher","DOI":"10.1002\/9781118338179.ch24"},{"key":"e_1_2_11_20_1","doi-asserted-by":"publisher","DOI":"10.1002\/9781119013020.ch06"},{"key":"e_1_2_11_21_1","volume-title":"Alternatives of plasma for transfusion to patients. Rapport fra Kunnskapssenteret nr. 5\u20132015","author":"Fr\u00f8nsdal K.","year":"2015"},{"key":"e_1_2_11_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/trf.14029"},{"key":"e_1_2_11_23_1","doi-asserted-by":"publisher","DOI":"10.1002\/9781118338179.ch16"},{"key":"e_1_2_11_24_1","first-page":"468","article-title":"Comparison of the hemostatic efficacy of pathogen\u2010reduced platelets vs untreated platelets in patients with thrombocytopenia and malignant hematologic diseases: a randomized clinical trial","volume":"4","author":"Garban F.","year":"2018","journal-title":"Journal of the American Medical Association\u00a0\u2013\u00a0Oncology"},{"key":"e_1_2_11_25_1","doi-asserted-by":"publisher","DOI":"10.1111\/vox.12323"},{"key":"e_1_2_11_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/voxs.12332"},{"key":"e_1_2_11_27_1","volume-title":"Of the Epidemics","author":"Hippocrates","year":"2014"},{"key":"e_1_2_11_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/trf.14509"},{"key":"e_1_2_11_29_1","unstructured":"Japanese Red Cross Society(2016).National Haemovigilance Report 2016. URLwww.jrc.or.jp\/mr\/english\/pdf\/Haemovigilance2016_en.pdf. Accessed 27\/8\/2018)."},{"key":"e_1_2_11_30_1","doi-asserted-by":"publisher","DOI":"10.1159\/000489900"},{"key":"e_1_2_11_31_1","article-title":"Approaches to understanding and interpreting the risks of red blood cell transfusion in neonates","author":"Keir A.K.","year":"2018","journal-title":"Transfusion Medicine"},{"key":"e_1_2_11_32_1","unstructured":"Krever H.(1997)Minister of Public Works and Government Services Ottawa Canada. Commission of Inqury on the Blood System in Canada. Final Report."},{"key":"e_1_2_11_33_1","doi-asserted-by":"publisher","DOI":"10.1111\/voxs.12248"},{"key":"e_1_2_11_34_1","doi-asserted-by":"publisher","DOI":"10.1111\/voxs.12084"},{"key":"e_1_2_11_35_1","doi-asserted-by":"publisher","DOI":"10.1111\/trf.13716"},{"key":"e_1_2_11_36_1","unstructured":"Muniz\u2010Diaz E. Leon G.&Torres O.(2015)Manual Iberoamericano de Hemovigilancia. URLhttps:\/\/www.paho.org\/hq\/dmdocuments\/2016\/Manual\u2010Iberoamericano\u2010de\u2010Hemovigilancia\u2010FINAL.pdf(Accessed 15\/9\/2018)."},{"key":"e_1_2_11_37_1","unstructured":"National Comparative Audit of Blood Transfusion(2017)Transfusion Associated Circulatory Overload Audit. URLhttp:\/\/hospital.blood.co.uk\/audits\/national\u2010comparative\u2010audit\/medical\u2010audits\/2017\u2010transfusion\u2010associated\u2010circulatory\u2010overload\u2010audit. Accessed 15\/9\/2018."},{"key":"e_1_2_11_38_1","unstructured":"National Haemovigilance Program of India(2017)Haemovigilance newsletter Vol. 5 Issue 9 January\u2013July 2017."},{"key":"e_1_2_11_39_1","unstructured":"National Institute for Health and Care Excellence(2015)Blood Transfusion Guideline (NG24). URLnice.org.uk\/guidance\/ng24(Accessed 15\/9\/2018)."},{"key":"e_1_2_11_40_1","unstructured":"New Zealand Blood Service National Haemovigilance Programme(2016)Annual Report 2016. URLhttps:\/\/www.nzblood.co.nz\/clinical\u2010information\/haemovigilance\u2010programme(Accessed 16\/9\/2018)."},{"key":"e_1_2_11_41_1","unstructured":"Politis C.(2018)ISTARE update. International Haemovigilance seminar July 2018 Manchester UK."},{"key":"e_1_2_11_42_1","doi-asserted-by":"publisher","DOI":"10.1111\/vox.12447"},{"key":"e_1_2_11_43_1","doi-asserted-by":"publisher","DOI":"10.1002\/9781118338179.ch12"},{"key":"e_1_2_11_44_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2010.03001.x"},{"key":"e_1_2_11_45_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1714977"},{"key":"e_1_2_11_46_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.15082"},{"key":"e_1_2_11_47_1","doi-asserted-by":"publisher","DOI":"10.1111\/vox.12631"},{"key":"e_1_2_11_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.transci.2013.09.013"},{"key":"e_1_2_11_49_1","doi-asserted-by":"publisher","DOI":"10.1111\/voxs.12452"},{"key":"e_1_2_11_50_1","unstructured":"Swissmedic Swiss Agency for Therapeutic Products Safety of Medicines Department(2016). Haemovigilance Annual Report 2016 (English). URLhttps:\/\/www.swissmedic.ch\/swissmedic\/en\/home\/humanarzneimittel\/market\u2010surveillance\/haemovigilance\/reporting\u2010undesirable\u2010effects\u2010of\u2010transfusion\u2010\u2010haemovigilance\u2010.html(Accessed 16\/9\/2018)."},{"key":"e_1_2_11_51_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2011.03074.x"},{"key":"e_1_2_11_52_1","unstructured":"TRIP Foundation(2016)Transfusion and transplantation reactions in patients. Annual report 2016. URLhttps:\/\/www.tripnet.nl\/en\/publications\/trip\u2010reports(Accessed 16\/9\/2018)."},{"key":"e_1_2_11_53_1","doi-asserted-by":"publisher","DOI":"10.1111\/trf.14359"},{"key":"e_1_2_11_54_1","doi-asserted-by":"crossref","first-page":"159","DOI":"10.21307\/immunohematology-2019-023","article-title":"Hemovigilance and the Notify library","volume":"33","author":"Whitaker B.I.","year":"2017","journal-title":"Immunohematology"},{"key":"e_1_2_11_55_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2010.02969.x"},{"key":"e_1_2_11_56_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1423-0410.2012.01659.x"},{"key":"e_1_2_11_57_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1423-0410.2012.01642.x"},{"key":"e_1_2_11_58_1","doi-asserted-by":"publisher","DOI":"10.1111\/voxs.12091"},{"key":"e_1_2_11_59_1","doi-asserted-by":"publisher","DOI":"10.1111\/voxs.12105"},{"key":"e_1_2_11_60_1","unstructured":"World Health Organization. (2015) Aide\u2010M\u00e9moire on haemovigilance. URLhttp:\/\/www.who.int\/bloodsafety\/haemovigilance. Accessed 14\/9\/2018."},{"key":"e_1_2_11_61_1","unstructured":"World Health Organization(2016)A Guide to Establishing a National Haemovigilance System. URLwww.who.int\/bloodsafety\/haemovigilance\/en(Accessed 27\/8\/2018)."}],"container-title":["Transfusion Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Ftme.12582","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/tme.12582","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/tme.12582","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/tme.12582","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,10]],"date-time":"2023-09-10T01:59:17Z","timestamp":1694311157000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/tme.12582"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,6]]},"references-count":60,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["10.1111\/tme.12582"],"URL":"https:\/\/doi.org\/10.1111\/tme.12582","archive":["Portico"],"relation":{},"ISSN":["0958-7578","1365-3148"],"issn-type":[{"value":"0958-7578","type":"print"},{"value":"1365-3148","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,6]]},"assertion":[{"value":"2018-11-05","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-01-12","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-02-06","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}